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This paper describes a sen s iti ve and specific immun o blo t-
ting procedure to dete~t Ro(SS-A ) an d Ll(SS-B) autoa nti-
bodies in t h e serum ot patien ts w it h lu p u s e r y thematos u s. 
In order to perform t hi s procedure , we have partially p u-
rified th e Ro(SS-A) and La(SS-1:3) antigen s from hum an 
spleen extra ts by DEAE- ccllulose an d Sep hacr y l S-300 
chronutography. The Ho(SS-A) and La(SS-B) antigens were 
immo bilized o n nitroce llulose pape r a fte r sodium dodecyl 
sulfatc-polyacry lan"lide gel electroph o res is and tested against 
a panel of se ra a t differellt diluti o ns: n orm al human se ra 
(n = 14) , R o(SS-A) antise r:r (n = 6), La(SS- B) (n = 7), 
Ro(SS- A) / LJ(SS- B) (n = 8), S m-n R N P-La(SS- B) (n 2). 
T boroug h sero logic eva lu :ni o n of patients w ith sus-pected syste mi c lupus erythem atosus (SLE) is ex -_ trem ely importan t in the dia gnos is and tn:atmcnt ot these patients. In the la st few ye:~ rs the sera of patients w ith SLE have been found to contain autoantJborlics 
aga inst extractable nuclear anti gens (E NA ) from different org::.r1s 
such as thymus, spleen, kIdney , or lym phoblasto id cells [ 1- :> J. 
Auroa ntibod ies agai nst Sm, Ro(SS-A), La(SS-13), and nRNP an-
tigens , wh ich arc present in ENA , arc com mo nl y eva lu ated in 
many clinica l laboratories. 
So me of th ese antibod ies appea r to be associated with specifi c 
subse ts ofS LE and Sjogren's syndro m e. For example, the Ro(SS-
A) and La(SS- B) antibodies appear ~o occur in a subset of lu pus 
patients and Sjogren 's sy ndro m e pat ients who possess pro m111 cnt 
dcr marologic features. Lupus Ro(SS-A) and La(SS- B) patients 
who demonstrate w idespread, intensely photosensiti ve lesions have 
been described under the headings of ANA-nega ti ve SLE [6], 
neona ta l lupus erythem atos us [7-9J, ho m ozygous C2 and C4 flOJ 
deficie n cies and a lu pus-li ke syndro me, and subacute cuta neo us 
lupus e rythem atosus [ll]. The almost universa l presence of Ro(SS-
A) and La(SS-B) in neonata l lu pus infants and thei r mothers con-
stitutes s trong ev idence that these tw o antibody system s may ha ve 
Manuscript received February 20. 1 9~5; accepted for publication july 
17, 1985. 
Su ppo rtcd in part by U.S. Pub li c He:tlth Service Gra nts HO I AM 3208 1, 
ROt AM 32599, and HOI Am 25650 from the Nationa l Inst itu tes of Health 
and a gift from the Estcc Lauder Co rporation. Dr. Halim is a postdoctora l 
fe llo w supported by the Amcrica-M idcast Educ:ltional & Tra tntng Ser-
vices , Inc., Washin gton, D.C. 
Reprint req uests to: Luis A. Din, M.D .. Department ofDennato logy. 
The J ohns Hopki ns University , 600 N . Wolf(: Street, ilaltimorc, Mary-
land 21202. 
A bbrcviations: 
ENA: extractable nuclear antigens 
PAGE: po lyacrylamide gel electrophoresis 
PMSF: phenyln lcthy lsu l[ony l fluoride 
SDS: sodium dodecy l sulfate 
SLE: sys temic lu pus nythemotosus 
We fo un d th at Ro(SS- A) ant ise ra react vvith a protein of 
an :r pprox im atc M,. of 58K, whereas the La(SS-B) an tisera 
reac ted with two bands of M,. 42 an d 40K, respectively. 
A n ti sera w ith both autoantibod ies [Ro(SS-A) and La(SS-
B) ] reacted with bo th J n tigens, w h e reas t h e cont ro l NH S, 
an ti -n R NP , an d anti-Sm d id n ot s ta in t h e R o(SS- A) and 
La(SS-13) prote in bands. In addi ti o n , som e of the positive 
se ra continued reactin g w ith th e respective antigens a t ex-
tremely h igh di lu tions. T his procedure can be easi ly adapted 
to test m an y se rum samp les :rnd produce data w hi ch include 
M, of the antigen an d titer of ::~ utoa ntibodics in th e patient 's 
se rum. J flt !'est Dcrt llatol 86:217-221, 1986 
a ca use and effect rcbtions hi p in producing the cl ini ca l features 
of lu pus in the infant, includin g the sk in d"isease [7.8[. Further-
m o re, the Ro(SS-A ) and La(SS-13) antibody syste m s occur in 
Sjog ren 's synd rome pati ents with promi nent systemic features 
incl uding cutaneous vascu lit is J1 2- 14 J. 
So me of the immunochemi ca l characte ri sti cs of the H.o(SS-A) 
and La(SS-13) amigcm extrac ted from hum an spleen and ca lfr hy-
rn us extracts, res pectively, were initi all y repo rted by C lark ct al 
J3], and Matt io li and H.eichli n [5]. T hese anti gens probably arc 
simil ar to those described b y Anderson et al in 1962 [1], and 
identica l to th e SSA and SSB ant igens as demonstrated by A l-
spa ugh and Mad ison f15]. Importa nt observatio ns made recently 
by Wo lin and Steitz [1 6, J 7] demonstrate that th e Ro(SS-A) and 
La(SS-B) anti gens arc co m plexes of sm all RNAs and a pro tein 
core. T he antigenic sire recognized by anti-Ro(SS- A) and anti-
La(SS- 13) autoantibodies appea rs to be located in the protein core 
of the n.N A- protein CO Ill pi exes [1 7]. Other immu nochcmi cal 
characterist ics of the H.o(SS-A) and La(SS-B) anti gens have also 
been reported recently [I 8 ] includin g molecu lar weight, isoelcc-
tri c point. etc. H O\.vcver, th e routine se ro logic eva lu ation of these 
autoa ntibod ies in clin ica l labo rator ies co ntinues to be performed 
by the do uble immunod iffus ion tech nique. Moreover , th e iden-
tification of anti-Ro(SS-A) and anti-La(SS- B) autoan tibodies in 
serum sa mples is acco mpli shed b y the reactio n of identity or 
non identity w ith standard pos itive sera. 
In an effort to define a mo re sensiti ve and specific assay to test 
the se ra of patients w ith SLE fo r Ro(S S-A) and La (SS-13) au to-
antibod ies, we have partiall y purifi ed the antigens from hum an 
spleen extracts and used them to set up im.munoblottin g teeh-
mqu cs. We found tlut the immun oblottin g techn ique usi ng the 
partia ll y purified ant igens is highly specifi c and sensitive for the 
detection and differentiat io n of Ro(SS- A) and La(SS-B) auto-
an tibodies. N o rmal hum an sera and other autoantibodi es such as 
those specific for Sm and n RNP, arc nonreactive w ith th ese par-
tia ll y pur ified antigens. It is expected that by usin g th is procedure 
it wi ll be possible to detect antibod ies fo r Ro(SS-A) and La (SS-
D) antigens in a hig hl y specifi c ::~ ud seusitive mJnncr in large 
numbers of clinica l serum sa mples. 
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M ATE RIALS AN D METH ODS 
Source and Extraction of Antigens l~o(SS- A) and La(SS- I3) 
an t igens were ex trac ted fro m hum an spleen fo ll ow in g _th e p ro-
ced ure described b y C lark ct a! 13 1 w tth so me m odth catto ns. 
Hum an spleens were obta in ed fro m autops ies perfo rm ed w tthtn 
24 h afte r death . Specimens were used tmm edt atcl y o r frozen at 
- 7!fC. T he spleen ca psule was removed and th e specim en min ced 
in sm all p ieces and ho m ogeni zed tw ice w ith a Po lytro n ho m og-
enizer fo r 3-4 min at 4°C in 0 .1 5 M N aCI, 0.05 M T ris/ H C I, pH 
7.2, (4: I v/ w, approx im atel y 400 ml of butTcr/ 1_00 g of wet 
weight of spleen), w ith 1.5 m M o f phen ylm eth ylsulton yl Auo n de 
(PM SF). 
Spleen ho m ogcnatcs were centri fuged for 30 min at 12,000 .e 
and the supern atant d ialyzed against 0. 15 M N aCI, 0 .05 M T ns/ HC I, 
pH 7 .2 at 4°C overni ght usin g a dialys is m em brane w ith a mo-
lecul ar we ight cu to!Ta t 12,000. The di alyzed spleen extract (ap-
prox im atel y 800 ml ) was th en applied to a D EAE-cellulosc co l-
umn equil ibrated w ith 0. 15 M NaCI, 0 .05 M Tris/1-l C I, pH 7.2. 
Stepwise elu tion of bo und pro tein s was perfo rm ed usin g 0 .3 M 
and 0.5 M N aC I in (J.U5 M T ri s/ 1-l C I, pH 7.2 (2 .5 x 30 rnl) . The 
elu ted frac ti ons (10 ml each) were poo led , d ialyzed aga inst H20 
overni gh t, and lyophilized. 
Partial Purification of Ro(SS-A) and La(SS-B) Anti-
gens Lyop hilized fracti ons (approxim ately 500 m g) fr o m th e 
DE A E- cellulose column were then separa ted b y gel fil tratio n 
chro m atog raph y on a Sephacryl S-300 colu m n (2.5 X 11 0 em). 
equilibrated w ith 0. 15 M N aC I, 0 .05 M T ri s/ H C I, pH 7.2. ln d t-
vidu al 10-m! sa mples were co llected . !VI,. standards we re run and 
the posi tion of each pro tein was reco rded . T he fo ll owin g stan-
dards we re used: blue dextran (!VI,. > 2 X 10('), albumin (M,. 
68 ,000), ova lbum in (M,. 45,000), chy m o trypsi nogen (M, 23,000), 
and ribonu clease (1\1[, 12,000). Representati ve pro tein peaks fro m 
hum an sp leen o bta ined by gel fi ltratio n we re poo led, concentrated 
by ultrafi ltration (A mi con U M-1 0 mem branes), aliquo ted , and 
frozen at - 70°C . 
Detection of Antigens During Extraction and Puri-
fi cation Ro(SS-A) and La(SS-I3) ant igens were detected d unn g 
pu rificatio n proced ures by do ubk immunodiffu s ion 11 9"1 and im-
mun oblo tting techni q ues usin g hum an an tise ra specific fo r th ese 
anti gens (sec bel ow) . 
Sources ofRo(SS-A), La(SS-B) , and Control Sera The fo l-
lowin g reference se ra we re empl oyed: Ro(SS-A) an tise ra (n = 
6), La(SS-B) antise ra (n = 7, in cludin g o ne sa mple from th e 
Cente rs fo r D isease Contro l, Atlan ta, Georgia), Ho(SS-A)/ La( S-
B) an tisera (n = 8), Sm-nRNP / La(SS-U) (n = 2), and norm al 
hum an sera (n = 14). T he specificity of the con tro l se ra has been 
described else where 19 1. T he sera we re tes ted at dilu tions va ryin g 
fro m 1 : 100 to 1 : 100,000. 
Polyacrylamide Gel Electrophoresis Polyacry lamide gel 
elect rophoresis (PA C E) using sod ium dodccyl sul fa te (S DS) was 
perfo rm ed fo ll owin g th e m eth od described by Laemmli [20 1 in 
11 - 18% acrylamid e gradient gel slabs usin g a rat io of ae ry lam ide 
to bis-ac rylamid e eq ual to 60 . Sa mples were prepa red fo r SDS-
PAGE by boilin g fo r 2 min in 2% SDS, 5 m M di thi o threito l, and 
5% beta-m ercaptoe th anol (ap prox im ate ly 30/ J.L g of to tal pro tein). 
Gels we re stained w ith Coom ass ie I3lue R-250 and scanned usin g 
a soft laser scannin g densito mete r (Bio med Instrum ents In c, Ful-
lerto n, Ca li fo rni a) w hi ch allows co mpute rized integ ration of in-
d ividu al peaks. T he fo llowin g pro tein standard s we re used to 
de termine M,: m yos in (210 K), ga lactos idase (120K), phospho-
ry lase (94K), albumin (68K), ovalbumi n (45 K), ca rboni c anh y-
drase (29 K). soybean tryps in inhibito r (20 K), and lysozy me (14.5K). 
Immunoblotting Procedures Pro tein s separated b y SDS-
PAGE were electro transferred to nitrocellul ose sheets [211 . T he 
nitrocell u lose sheets we re incubated fo r 3 h in 3% bovi ne se rum 
album in to block nonspecific binding sites and th en the nitro-
cellulose str ips were washed ex tensi vel y w ith 0.01 M Tris/ H C I, 
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0. 14 M N aCI, 0.5% N o ni de t P-40, pH 7.6 (washin g buffe r), and 
subseq uentl y t rea ted w ith th e appro priate dilutio n o f tes t sera 
( 1 : 100 o r hi ghe r) fo r 2 h at 37°C. After ano ther intensive w ashin g , 
th e strips we re in cubated w ith a 1 : I 000 dilutio n o f perox idase-
labc k d goat an tihum an lgG (Ca ppel Labs, Cochransv dlc ,_ Pen n-
sylva ni a) diluted in was hin g bu ffer. T h t: Ia t wash was pe rto rmed 
w ith 0.05 M Tris base, pH 7.6 . T he co lo r reactio n was deve loped 
w ith 40 m g of 3,3' - d iamin obenzidin e and 40 J.Ll of l-h02 in 100 
ml of0.05 M Tri s pl-1 7.6. 
RES ULTS 
Extraction and Partial Purification ofRo(SS-A) and La(SS-
B) Antigens Ro(SS-A) and La(SS- B) anti gens were extracted 
fro m hum an spleen ho m oge nates and were recognized b y an ti-
Ro(SS-A) and anti-La(SS-B) m onos pecifi c anrise rum. W e fo u nd 
th at th e additi o n o f PM SF durin g ex trac tio n procedures preser ved 
th e ac ti vity of both anti ge ns. Ro(SS-A) and La(SS-B) anti gens 
were bound by DE AE- cellulose equilibrated w ith 0. 15 M N aCl, 
0 .05 M T ris/H C I, pH 7.2 buffer; subseq uen tly th ey were released 
by 0.3 M N aC I in th e sa m e buffer. The 0.5 M N aC l frac ti o n eluted 
fr o m the D E A E-ccllulose column was in ac tive fo r these antigens. 
T he U.3 M N aC I fracti on fro m the DEAE- cellulose co lumn con-
tai nin g Ro(SS-A) and La(SS- B) an tigeni c acti v ity was separated 
in several co m ponents by th e Sephacry l S-300 co lumn as shown 
in Fig 1. Ro(SS-A) and La(SS-B) anti gens eluted consistentl y as 
a sm all pt:a k immed iate ly after albumin and befo re ova lbumin. 
SDS-PAGE Analysis and lmmunoblotting of the Ro(SS-
A) and La(SS-B) Antigens SD S-PAGE an alys is o f th e active 
peak fro m th e Sephacryl S- 300 column and its scan are shown in 
Fig 2. As set:n in thi s fi gure th e bands co rrespo ndm g to Ro (SS-
A) and La(SS- B) anti gens (identifi ed b y immuno blottin g) con-
stitute onl y a small am o unt of the to tal pro tein applied to the 
gel s. Inte res tin g ly, all ]{o(SS-A ) antisera (n = 6) recognized a 
band w ith an apparent M, o f 58,000, w hereas La (SS-B) antisera 
(n = 7) recog nized 2 bands w ith M , of 42 ,000 and 40,000. The 
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Figure 1. Scphacryl S-300 chromatograph y of hu rm n spleen Ro(SS-A) 
ami La(SS-13) anri gm s. Approx im ately 300 mg of human spleen proteins 
present in the 0.3 M NaCI frac tion of the DE AE-ccllulose purification 
step (sec Mcrlwds) were dissolved with 3 ml of 0. 15 M NaCI, 0.05 I 
T ris/ HCI bu tTer pH 7.2 and applied to the column . M, standards an> 
incl uded as fo ll ows: blue dex tran (> 2000 K). albumin (68 K). ovalbumin 
(45K). chymotrypsinogen (23 1< ), and ribonuclease (12K). T he Ro(S -A) 
and La(SS- 13) antigens chromatographcd in the region between albumin 
and ova lbumin (shaded pl'ak). 
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Figure 2. SDS-I'A GE :1 nalys is of partia ll y puritied l~o(SS-A) and La(SS-
B) anti gens (ac ti ve peak fro m the Scp hacry l S-300 chro m:.ttog r:un). ~he 
sca n of rhc ge l is also show n md1catmg the loca no n and M, of the Ro(SS-
A) a nd La (SS-13) antigens. The M, s ta ndards arc inclu ded: ga lactos idase 
(120K) p hos p lwry l:! se (<J2 K). albnlllin (6t! K). ov:d bumin (-ISK), carboni C 
anhyd rase (2';1 K). soy bea n tryps in inh ibitor (2U K). and lysozy n1e ( 1--I .S K). 
seru m specimens co mainin g bo th Ro(SS-A) and La(SS- B) ami-_ 
bodies (n = 8), both bands were dem o nstrated. The pa nel o f 
con tro l se ra including those w ith 11 RN P and Sm specificity (n = 
2) , o r NH S (n = 14) did no t react w ith the pro tein bands rec-
ogni zed by Ro(SS-A ) and La (SS-B) antibodies . In th ose se rum 
sam ples con taining nRNP, Sm. and La(SS- B) auroa tt t tbodtcs onl y 
the bands recogn ized by the La(SS-U) ant isera we re demonstrated. 
Titration of Ro(SS-A) and La(SS-B) Antibodies by Im-
munoblotting Procedures T he sensitivit y o f the immuno-
blottin g techniques usin g partiall y purified Ro(SS-A) and La (SS-
B) an ti gens in detec tin g Ro(SS- A) and La (SS-J3) autoa11tibodi es 
present in patient se ra was extre m ely hi gh . As seen in Fi ~ 3, hi gh 
dilu tio ns of Ro(SS-A) and La(SS-B) ·era co ntnw ed reactmg w1th 
the b lotted Ro (SS-A) and La(SS-B) ami gens by immuno blo ttin g 
procedures. NI-l S di lutio ns were negat ive. 
DISC U SS ION 
This in ves tigat io n shows that partiall y purified l ~o(SS-A ) and 
La(SS-B) anti gens fro m hunun spleen extrac ts react specifica ll y 
w ith hum an antoa ntibod ies from SLE pat ients b y immuno blot-
ting techni q ues. The pro tein ba nds recogni zed by l ~o(SS- A) and 
La(SS- B) autoantibodies arc unique and specifi ca ll y react w tth 
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e;~ch of these an tibod ies . Sera fr o m patients containing on ly one 
o t these autoantibod ies , i.e., Ro(SS-A ), reacted with o nly one 
protei n band of M , 5H K w hereas the se ra fro m patients w ith 
La ( S-B) autoantibod ies reacted w ith 2 b;mds, one of 40K and 
another of 32K. Sera co nta ining both Ro(SS-A) and La (SS-1:3) 
autoa ntibod ies rea cted with both prote in bands . As shown in Fig 
-+ , the Ro(SS-A) and La (SS-B) bands detected by immun o blo ttin g 
were also shown usin g different di luti ons of the res pective hu man 
se ra , all owing the titration of the autoa ntibo dies by thi s proce-
du re. Sera fro m pat ients w ith antibodi es aga inst nRNP, Sm, o r 
no rma l hum an sera did not rea ct with either of these protein 
bands. 
T he proced ures used to ext rac t and parti all y purify these an-
ti gens was a m od ified ·ersion of the in itial method repo rted by 
C ia rk et al I 31; bri efl y, the extractio n was perfo rmed w ith 0. 15 
M N aC l, 0.05 M Tris/ H C l, pH 7.2 buffer and 1.5 m M PMSF. 
T he so lubili zed Ro(SS- A) and L:1(SS-B) antigens were bo un d by 
DEA E-cellulose equ librated wi th the sa m e extrac tion buftc r and 
then re leased by 0 .3 M N a I. This fracti o n reacted w ith Ro(SS-
A) and La(SS-B) se ra by doub le immunod iffusio n; however, this 
crud e preparation reveal ed by immuno blotti ng, in add itio n to the 
H.o(SS-A ) and La (SS-B) antigens, severa l nonspecifi c bands w hen 
test in g control se ra. T o eli min ate these no nspecifi c ba nds. we 
further purifi ed the Ro(SS-A) and La (SS-B) antigens by gel fi l-
tration chrom atograph y usin g Scphacry l S-300 equi librated w ith 
0. 15 M N aCI. 0.05 M T ris/ H C l, pH 7.2. The anti gens e lu ted as 
a sin gle peak in a regio n between albumin (M, 68.000) and oval-
bumin (!\/, 45,000) . T he analys is of the SDS-PAGE of this pea k 
showed severa l co m po nents, bur onl y 3 of these bands reacted 
w ith l ~o(SS-A) and L::~ (SS-B) autoantibodies. T heM, of the Ro(SS-
A) and La(SS-1:3) antigens obtained by gel fi ltrati on chro m atog-
raph y were co nco rdant to th ose fo un d by SDS-PA GE. T he ap-
prox imate M,. fo r the anti gens recognized by autoa ntibodies pres-
ent in Ro (SS-A) sera and those present in La(SS- 13) sera arc in 
ag reement w ith recent studies on the immunochemi ca l ch ::~rac­
te ri sti cs of these anti gens I 17. 18,22-24]. 
In add ition to double immunodiffusion, the H.o(SS- A) and La(SS-
l3 ) ami gens have been detected recently by ditTerenr techniq ues . 
Some in vestigators have metaboli ca ll y rad io labeled cellular an-
ti gens fro m cell lines incubated wi th I-'5S]methi oninc or 32 J->0 4 
I 17,25,26 1. T he rad io labcled antigen: were tested agai nst the sera 
o f patients w ith Ro(SS-A) o r La(SS-B) autoa ntibodies by im-
munoprecipitation procedures. T he immunoprecipitates were then 
analyzed b y SDS-PAGE and auto radiography. O ther investi ga-
tors have used immunoadso rbcnt co lumns to prepare Ro(SS-A) 
and La(SS-B) an tigens fro m tiss ue o r ce ll extrac ts , linking the 
IgG fra cti on fro m a pos iti ve Ho(SS- A) o r La (SS-B) sera to Se-
ph ~t rose 4B J22-2-+J. T he purifi ed anti gens have been used to 
:111 alyzc patients' sera by en zym e-lin ked immunoso rbent assay 
II 
Figure 3. lm munoblo tting analys is of partiall y purifi ed hum an sp leen Ro(SS-A)/ L:1 (SS-B) ami gens and a rcprcscmativc panel of Ro(SS-A) and La(SS-
B) se ra (/a 11 es 1-4), Ho(SS-A) se ra (/a li i'S 5-8), La (SS- B) se ra (ln11cs 9- 12). and no rm al hum an sera (/n 11es 13-16) at 1:1 00 di lut io n. T he l ~o(SS-A) anti se ra 
reac ted w ith a pro te in band of M, SS K (s hown by 111'1'<>11'), the La(SS-13) amisera reacted w ith 2 close bands o f 40K and 42K (shown by mTOII ') , respectivel y. 
Antise ra w ith l~ o(SS-A ) and La(SS-13) specific ities n:acted w ith bo th g ro ups of pro teins. N o r m al hum an se ra did not show reacti vity. M,. standards 
are listed o n th e ldt of line I as fo llows: (a) phos pho ry lase (';l4K) . (b) albumin (6H K). (c) ova lbumin (45 K). and (d) soybea n try psin inhibitor (2UK). 
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Figure 4. Titration of controls (n = 14), Ho(SS-A) (n = 6), La(SS-13) 
(n = 8), and La(SS-D) (n = 8) by immunoblo ttin g technique using the 
p;mia lly purified Iutman spleen Ro(SS-A) and La(SS-J3) antigens. The 
cloml and opened circles in the Ho(SS-A) and La(SS-B) column represent 
the end point titer at which a particu lar Ro(SS-A) o r La(SS-B) serum 
produces a definite stai ning of the ant igens. The llllriiiJ<• rerl closed 111111 opCIIcd 
cir·clcs (a pair of simi lar numbers ident ify a sin gle seru m sample) in the 
Ro(S -A)/La(SS-13) column represent the end point titer for each au-
toantibody present in 8 se ra tested and produ cing a positive stainin g of 
the respective antigens. The trin11gles of the control column represent 
control sera producin g no slai ning of the l~o(SS-A) and La(SS-13) anti gens 
at the I: 100 di lution. 
(ELISA) [23,24] , radioimmunoassay usin g 125 1-labeled antigen 
122,23 J, and recentl y by immuno blotting procedure [17, 18,24] . 
The similarity o n immunochemica l properties of Ho (SS-A) and 
La(SS-B) antigens described in th ese previous studies and our 
own findings su ggest that the p arti ally purified an ti gens from 
hum an spleen extracts provide an excellent source of R o(SS-A) 
and La(SS-B) antigens. These antigens ca n be used to test large 
numbe rs of clinical sa mples by immunoblotting proced ures. The 
results a re specifi c and extremely sensitive providing info rmation 
on both M, of the anti gen s and the titers of autoantibod ies in the 
patient' s se ra. 
Our s tudies h ave detected 4 sera co ntainin g significant quan-
tities of La(SS-B) in the apparent absen ce of Ho(SS-A) antibodies. 
This is a su rpr is in g finding beca use prev io us wo rk in o ur and 
o th er labo rato ries had on ly rarel y detected La (SS-B) in the a bsen ce 
of Ro(SS-A) antibod ies . Other inves ti gators have reported a close 
relationship between Ro(SS-A) and La(SS-B) antibody titers us-
in g a counterimmunoelectrophoresis technique f27J. The rea-
son(s) fo r these disco rdant observatio ns is/a rc unknown . Con-
ceivably, the bo ilin g and SDS redu ction prior to immunoblotting 
cou ld have des troyed so me antigenic determ inants on t he Ro(SS-
A) antigens. On the other h and, t h is sensitive technique may be 
indeed detec ting the presen ce ofLa(SS-B) in the absen ce ofRo(SS-
A) antibo di es. 
Fina ll y, Deng ct al l28] have just published simi lar data dem-
o nst ratin g that Ro(SS-A) and La(SS-B) have M, of ap prox im ately 
60 K and 43K, respectivel y. 
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